Key facts
- Medicare reforms have capped insulin costs for covered beneficiaries at $35 per month.
- An estimated 3.5 to 4 million seniors aged 65 and older use insulin to manage diabetes.
- Approximately one in three seniors has diabetes, with a significant portion requiring daily insulin.
- The $35 monthly cap on insulin prescriptions has led to substantial savings for many older adults.
The rising cost of insulin has been a major concern for retirees and advocacy groups for years. Recent Medicare reforms have introduced a $35 monthly cap on insulin prescriptions for beneficiaries, significantly reducing out-of-pocket expenses for millions of older adults who rely on this life-saving medication to manage their diabetes.